CTRI/2024/01/061381
Not yet recruiting
Phase 2
Extra Fluid supplementation in management of unconjugated hyperbilirubinemia in preterm neonates-A randomized controlled trial. - nil
Aradhana0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Aradhana
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Preterm neonate (29\-33 \+6\) with severe unconjugated hyperbilirubinemia during first two weeks of life.
Exclusion Criteria
- •Jaundice \<24 h, multiple congenital malformation, stage 2 \&3 AKI, FiO2 \> 40%, symptomatic PDA or CHD, neonatal encephalopathy, TSB level above 5mg/dl of exchange transfusion threshold
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Conservative fluid management for adult patients with acute respiratory distress syndrome: a systematic review and meta-analysisacute respiratory distress syndromeJPRN-UMIN000040955Mie University
Active, not recruiting
Not Applicable
Goal Directed fluid substitution at patients with proximal femoral fracture. Evaluation of costs and consequences of alternative strategies of intra -opertaive fluid substitution- randomised clinical trial - Goal directed fluid substitution at patients with proximal femoral fracturePatients suffering from proximal femoral fracture.EUCTR2009-018087-10-SEKarolinska University Hospital Huddinge
Completed
Not Applicable
The effect of restriction of fluid in treatment of transient tachypnea of newborTransient tachypnea of newborn.Transient tachypnea of newbornIRCT2015122225650N1Vice chancellor for research, Babol University of Medical Sciences70
Completed
Not Applicable
Optimum fluid therapy to minimize the postoperative complications of long surgery : randomized controlled trialGastrointestinal SurgeryJPRN-UMIN000022459Kyorin University260
Active, not recruiting
Phase 1
Steering of administration of intravenous fluids and vasoactive drugs towards set goals during surgery for removal of the esofagus because of cancerAnesthesia for esophageal resection because of malignancyTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]EUCTR2011-000254-39-SEAnestesi och Operationskliniken65